Johns Hopkins University
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Johns Hopkins University reported 14 stock positions worth $2.7 billion. Its top holding was iShares MSCI Acwi ETF (ACWI) at 27.8% of the portfolio, followed by iShares 1-5Y Inv Grade (IGSB, 19.5%) and Vanguard Int-Term Corporate (VCIT, 15.7%). Compared with Q2 2024, it opened 3 new positions, sold out of 5, added to 6 and reduced 3. The biggest buy was iShares Russell 1000 ETF (IWB, shares +293%) and the biggest sale Vanguard Long-Term Corp. Bond (VCLT, shares −54%).
- Most Recent 13F
- Q2 2026
- Location
- BALTIMORE, MD
- CIK
- 0001764756
- Portfolio Value
- $2.7B (Q3 2024)
- SEC Filing
- 0001764756-24-000009 ↗ filed Nov 14, 2024
Holdings Value
Holdings 14 stocks · $2.7B
| ACWI iShares MSCI Acwi ETF | 27.85% | 6,216,366 | $743.2M | Add +4.7% |
| IGSB iShares 1-5Y Inv Grade Corp. | 19.46% | 9,861,945 | $519.3M | Add +8.0% |
| VCIT Vanguard Int-Term Corporate | 15.65% | 4,988,327 | $417.8M | Add +6.4% |
| IWD iShares Russell 1000 Value E | 7.86% | 1,105,404 | $209.8M | Add +77.4% |
| IWB iShares Russell 1000 ETF | 7.48% | 634,929 | $199.6M | Add +293.5% |
| VCLT Vanguard Long-Term Corp. Bond | 7.33% | 2,409,010 | $195.7M | Reduce -54.5% |
| TLH iShares 10-20 Year Treasury | 4.90% | 1,196,677 | $130.8M | Add +11.3% |
| VGSH Vanguard Short-Term Treasury | 4.56% | 2,061,065 | $121.6M | New |
| IWM iShares Russell 2000 ETF | 2.27% | 274,564 | $60.6M | Reduce -45.4% |
| VGIT Vanguard Intermediate-Term T | 1.55% | 682,604 | $41.2M | New |
| IEF iShares 7-10 Year Treasury B | 1.05% | 286,376 | $28.1M | No change |
| VTI VG Morningstar TS MKT ETF-US | 0.01% | 1,213 | $343K | Reduce -6.2% |
| IOT Samsara Inc. Class A | 0.01% | 5,974 | $287K | New |
| BRNS Barinthus Biotherapeutics PL | 0.01% | 122,237 | $145K | No change |
Portfolio Sells Q2 2024 → Q3 2024
| VCLT Vanguard Long-Term Corp. Bond | Reduce -54.5% | 7.33% | −8.69 |
| XOP SS SPDR S&P Og Exp & Prod | Sold out | 0.00% | −2.64 |
| IWM iShares Russell 2000 ETF | Reduce -45.4% | 2.27% | −1.80 |
| XBI SS SPDR S&P Biotech ETF | Sold out | 0.00% | −1.68 |
| IBB iShares Biotechnology ETF | Sold out | 0.00% | −1.26 |
| EEM iShares MSCI Emerging Market | Sold out | 0.00% | −1.21 |
| IWO iShares Russell 2000 Growth | Sold out | 0.00% | −1.08 |
| VTI VG Morningstar TS MKT ETF-US | Reduce -6.2% | 0.01% | −0.00 |
Portfolio Buys Q2 2024 → Q3 2024
| IWB iShares Russell 1000 ETF | Add +293.5% | 7.48% | +5.56 |
| VGSH Vanguard Short-Term Treasury | New | 4.56% | +4.56 |
| IWD iShares Russell 1000 Value E | Add +77.4% | 7.86% | +3.52 |
| VGIT Vanguard Intermediate-Term T | New | 1.55% | +1.55 |
| ACWI iShares MSCI Acwi ETF | Add +4.7% | 27.85% | +1.21 |
| IGSB iShares 1-5Y Inv Grade Corp. | Add +8.0% | 19.46% | +0.78 |
| VCIT Vanguard Int-Term Corporate | Add +6.4% | 15.65% | +0.70 |
| TLH iShares 10-20 Year Treasury | Add +11.3% | 4.90% | +0.49 |
| IOT Samsara Inc. Class A | New | 0.01% | +0.01 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 18 | $1.5B | AGG, QQQ, EMXC, IWB, GNR |
| Q1 2026 | 13 | $1.4B | AGG, QQQ, GNR, EMXC, IWB |
| Q4 2025 | 14 | $1.4B | AGG, QQQ, EMXC, IWB, GNR |
| Q3 2025 | 16 | $1.8B | AGG, QQQ, IWB, EMXC, GNR |
| Q2 2025 | 19 | $1.9B | AGG, QQQ, EMXC, IWB, GNR |
| Q1 2025 | 15 | $2.7B | AGG, ACWI, IWB, IWD, EFV |
| Q4 2024 | 14 | $2.7B | AGG, ACWI, IWD, IWB, VGSH |
| Q3 2024 | 14 | $2.7B | ACWI, IGSB, VCIT, IWD, IWB |
| Q2 2024 | 16 | $2.5B | ACWI, IGSB, VCLT, VCIT, TLH |
| Q1 2024 | 17 | $2.6B | ACWI, IGSB, VCIT, VCLT, IWM |